Official Title: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A
Actual Study Start Date : October 30, 2022
Estimated Primary Completion Date : July 31, 2023
Estimated Study Completion Date : July 31, 2024